Status:
COMPLETED
Remdesivir Efficacy in Coronavirus Disease
Lead Sponsor:
Tanta University
Conditions:
COVID
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
COVID 19 treatment using Remedesvir.
Detailed Description
COVID 19 treatment using Remedesvir. Is this drug effective?
Eligibility Criteria
Inclusion
- COVID 19 patients
Exclusion
- allergy or contraindication to the drug
Key Trial Info
Start Date :
June 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04345419
Start Date
June 16 2020
End Date
December 1 2020
Last Update
August 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta university hospital, Assuit University, Ainshams University
Tanta, Egypt